Robert S. Witte
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
Papers in
-
- Renal cell carcinoma treatment 4
- Methemoglobinemia and Tumor Lysis Syndrome 2
- Oncology 8
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Paul J. Elson (6 shared papers)Donald L. Trump (7 shared papers)Patrick J. Loehrer (3 shared papers)Richard H. Knop (1 shared paper)Bartholomew R. Bono (1 shared paper)Robert Dreicer (1 shared paper)D L Trump (2 shared papers)Ronald H. Blum (1 shared paper)
- Journals
- Investigational New Drugs (8 papers)Cancer (3 papers)Journal of Clinical Oncology (2 papers)The Journal of Chemical Physics (2 papers)Journal of Applied Physics (2 papers)
- Partner nations
- United StatesSouth AfricaGermany
In The Last Decade
Robert S. Witte
34 papers receiving 987 citations
Peers
Comparison fields: 5 of 108
- Pulmonary and Respiratory Medicine 405
- Oncology 328
- Cancer Research 109
- Surgery 291
- Molecular Biology 217
Countries citing papers authored by Robert S. Witte
This map shows the geographic impact of Robert S. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Witte more than expected).
Fields of papers citing papers by Robert S. Witte
This network shows the impact of papers produced by Robert S. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Witte. The network helps show where Robert S. Witte may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Witte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. | 1988 | 280 |
| 2 | 1997 | 165 | |
| 3 | 1996 | 110 | |
| 4 | Phase I study of vinblastine and verapamil given by concurrent iv infusion. | 1985 | 71 |
| 5 | 2003 | 57 | |
| 6 | 1994 | 41 | |
| 7 | 1998 | 40 | |
| 8 | 1991 | 37 | |
| 9 | 1987 | 33 | |
| 10 | 1986 | 22 | |
| 11 | 1996 | 19 | |
| 12 | 1951 | 18 | |
| 13 | 1962 | 18 | |
| 14 | 1999 | 17 | |
| 15 | 2000 | 15 | |
| 16 | 1963 | 14 | |
| 17 | 1964 | 13 | |
| 18 | 1962 | 12 | |
| 19 | 1992 | 12 | |
| 20 | 2000 | 12 |
About Robert S. Witte
Robert S. Witte is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Reproductive Medicine, Molecular Biology and Neurology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Lung Cancer Research Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers), Peptidase Inhibition and Analysis (2 papers), Methemoglobinemia and Tumor Lysis Syndrome (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (405 citations), Oncology (328 citations), Cancer Research (109 citations), Surgery (291 citations) and Molecular Biology (217 citations). Robert S. Witte has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Paul J. Elson, Donald L. Trump, Patrick J. Loehrer, Richard H. Knop, Bartholomew R. Bono, Robert Dreicer, D L Trump, Ronald H. Blum, Roger A. Schinella and Geoffrey Falkson. Their work appears in journals such as Investigational New Drugs, Cancer, Journal of Clinical Oncology, The Journal of Chemical Physics and Journal of Applied Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.